CLINICAL TRIAL PROTOCOL TITLE: A PHASE 1/2 STUDY OF REGN22530 IN PARTICIPANTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION

Registry ID

R22530-IOP-2558

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

REGENERON PHARMACEUTICALS INC

Last update

2026-07-10

Conditions

• OPEN ANGLE GLAUCOMA

Related clinical trials

• PROSPECTIVE, MULTICENTER STUDY OF THE PRESERFLO MICROSHUNT IN SUBJECTS WITH PRIMARY OPEN-ANGLE GLAUCOMA WHO HAVE FAILED PREVIOUS MEDICAL AND SURGICAL TREATMENT

View on source registry